New York State Common Retirement Fund Instil Bio, Inc. Transaction History

New York State Common Retirement Fund

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$0.51 - $0.67 $21,484 - $28,225	-42,127 Reduced 98.79%	514 $0
Q4 2022 Jan 30, 2023	BUY	$0.48 - $5.33 $37 - $415	78 Added 0.18%	42,641 $27,000
Q3 2022 Nov 08, 2022	BUY	$4.65 - $7.37 $1,357 - $2,152	292 Added 0.69%	42,563 $206,000
Q2 2022 Aug 04, 2022	SELL	$4.21 - $11.15 $244,377 - $647,224	-58,047 Reduced 57.86%	42,271 $195,000
Q1 2022 May 05, 2022	BUY	$8.48 - $18.1 $121,374 - $259,065	14,313 Added 16.64%	100,318 $1.08 Million
Q4 2021 Feb 02, 2022	BUY	$15.37 - $22.5 $239,449 - $350,527	15,579 Added 22.12%	86,005 $1.47 Million
Q3 2021 Nov 02, 2021	BUY	$15.05 - $23.28 $142,267 - $220,065	9,453 Added 15.5%	70,426 $1.26 Million
Q2 2021 Aug 02, 2021	BUY	$15.31 - $24.63 $630,190 - $1.01 Million	41,162 Added 207.77%	60,973 $1.18 Million
Q1 2021 May 11, 2021	BUY	$24.23 - $27.06 $480,020 - $536,085	19,811 New	19,811 $497,000

1.9M

Ticker TIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,694,000
Market Cap $3.23B
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.